Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:activeIngredient |
gptkb:clindamycin
|
| gptkbp:approvedBy |
gptkb:FDA
1970 |
| gptkbp:ATCCode |
J01FF01
|
| gptkbp:contraindication |
hypersensitivity to clindamycin
|
| gptkbp:drugClass |
lincosamide antibiotic
|
| gptkbp:eliminationHalfLife |
2-3 hours
|
| gptkbp:excretion |
urine
feces |
| https://www.w3.org/2000/01/rdf-schema#label |
Cleocin
|
| gptkbp:indication |
skin infections
pelvic inflammatory disease respiratory tract infections dental infections bone and joint infections acne (topical) |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (oral, US)
|
| gptkbp:routeOfAdministration |
oral
topical intramuscular intravenous |
| gptkbp:sideEffect |
gptkb:pseudomembranous_colitis
nausea diarrhea rash |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Clindamycin
gptkb:clindamycin |
| gptkbp:bfsLayer |
7
|